These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6689106)

  • 1. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug.
    Okimasu E; Moromizato Y; Watanabe S; Sasaki J; Shiraishi N; Morimoto YM; Miyahara M; Utsumi K
    Acta Med Okayama; 1983 Oct; 37(5):385-91. PubMed ID: 6689106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glycyrrhizin on lysosomes labilization by phospholipase A2.
    Shiki Y; Ishikawa Y; Shirai K; Saito Y; Yoshida S
    Am J Chin Med; 1986; 14(3-4):131-7. PubMed ID: 3799529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycyrrhizin on stability of lysosomes in the rat arterial wall.
    Shiki Y; Sasaki N; Shirai K; Saito Y; Yoshida S
    Am J Chin Med; 1986; 14(3-4):138-44. PubMed ID: 3799530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phospholipase A2 by tiaramide in rabbit platelets.
    Takano S
    Jpn J Pharmacol; 1985 Nov; 39(3):307-16. PubMed ID: 3005729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
    Vallee E; Gougat J; Navarro J; Delahayes JF
    J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of phospholipase A2 activity by the tumour promoters phorbol esters and teleocidin.
    Nam KY; Morino A; Kimura S; Fujiki H; Imanishi Y
    Biochem J; 1990 May; 268(1):169-73. PubMed ID: 2344355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody.
    Shiki Y; Shirai K; Saito Y; Yoshida S; Mori Y; Wakashin M
    J Gastroenterol Hepatol; 1992; 7(1):12-6. PubMed ID: 1543863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inhibitory action on platelet activation of a phospholipase A2 isolated from Lachesis muta (Bushmaster) snake venom.
    Fuly AL; Machado OL; Alves EW; Carlini CR
    Thromb Haemost; 1997 Nov; 78(5):1372-80. PubMed ID: 9408022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BE-I-PLA2, a novel acidic phospholipase A2 from Bothrops erythromelas venom: isolation, cloning and characterization as potent anti-platelet and inductor of prostaglandin I2 release by endothelial cells.
    de Albuquerque Modesto JC; Spencer PJ; Fritzen M; Valença RC; Oliva ML; da Silva MB; Chudzinski-Tavassi AM; Guarnieri MC
    Biochem Pharmacol; 2006 Jul; 72(3):377-84. PubMed ID: 16750518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.
    Kohler C; Carroll M; Tarrant E; Torley L; Wissner A
    Inflammation; 1993 Jun; 17(3):245-61. PubMed ID: 8330926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation by cepharanthine is accomplished during the early, membrane-related activation process.
    Watanabe S
    Acta Med Okayama; 1984 Apr; 38(2):101-15. PubMed ID: 6731025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
    Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
    Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a glycyrrhizin (GL)-binding protein and the GL-induced inhibition of the CK-II-mediated stimulation of sPLA2-IIA activity in vitro.
    Shimoyama Y; Sakamoto R; Akaboshi T; Tanaka M; Ohtsuki K
    Biol Pharm Bull; 2001 Sep; 24(9):1004-8. PubMed ID: 11558558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and inhibitor sensitivity of human sperm phospholipase A2: evidence against pivotal involvement of phospholipase A2 in the acrosome reaction.
    Anderson RA; Johnson SK; Bielfeld P; Feathergill KA; Zaneveld LJ
    Mol Reprod Dev; 1990 Dec; 27(4):305-25. PubMed ID: 2264993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a direct inhibitory effect of glucocorticoids on the activity of phospholipase A2 as a further possible mechanism of some actions of steroidal anti-inflammatory drugs.
    Mentz P; Giessler C; Förster W
    Pharmacol Res Commun; 1980 Sep; 12(8):817-27. PubMed ID: 7443764
    [No Abstract]   [Full Text] [Related]  

  • 16. Cascade liposomal triggering: light-induced Ca2+ release from diplasmenylcholine liposomes triggers PLA2-catalyzed hydrolysis and contents leakage from DPPC liposomes.
    Wymer NJ; Gerasimov OV; Thompson DH
    Bioconjug Chem; 1998; 9(3):305-8. PubMed ID: 9576803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
    Norris JF; Ilderton E; Yardley HJ; Summerly R; Forster S
    Br J Dermatol; 1984 Jul; 111 Suppl 27():195-203. PubMed ID: 6743552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of protein phosphatases 1 and 2A in collagen-platelet interaction.
    Chiang TM
    Arch Biochem Biophys; 1993 Apr; 302(1):56-63. PubMed ID: 8385905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide.
    Jacobson PB; Marshall LA; Sung A; Jacobs RS
    Biochem Pharmacol; 1990 May; 39(10):1557-64. PubMed ID: 2337412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of liposomes surface-modified with glycyrrhizin to the liver. I. Preparation and biological disposition.
    Tsuji H; Osaka S; Kiwada H
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):1004-8. PubMed ID: 1893485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.